Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study

Reproductive BioMedicine Online

Volumn 3, Issue 3, 2001, Pages 190-194

  Lisi, F ^a   Rinaldi, L ^a   Fishel, S ^a,b   Lisi, R ^a   Pepe, G ^a   Picconeri, M G ^a   Campbell, A ^a,b   Rowe, P ^c  

^a Casa di Cura Villa Europa all'EUR   (Italy)

^b Park Hospital   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

follicle growth; human; IVF; ovarian stimulation; recombinant FSH and LH

Indexed keywords

RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION; HUMAN; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; PILOT STUDY; PREGNANCY;

EID: 85006165910     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62034-2     Document Type: Article

References (36)

1. Agrawal, R, West, C, Conway, GS, et al. Pregnancy after treatment with three recombinant gonadotrophins. Lancet 349 (1997), 29–30.
2. Agrawal, R, Conway, GS, Engmann, L, Implication of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization. Gynecological Endocrinology 12 (1988), 9–15.
3. Andersen, CY, Ziebe, S, Xia, Guoliang, et al. Requirement for human gonadotropin and recombinant human luteinizing hormone for follicular development and maturation. Journal of Assisted Reproduction and Genetics 16 (1999), 425–430.
4. Balash, J, Miro, F, Burzaco, I, et al. The role of luteinising hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilisation in a woman with longstanding hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Human Reproduction 10 (1995), 1678–1683.
5. Chandrasekher, YA, Hutchinson, JS, Zelinski-Wooten, MB, et al. Initiation of periovulatory events in primate follicle using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. Journal of Clinical Endocrinology and Metabolism 79 (1994), 298–306.
6. Chappel, S, Howles, C, Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Human Reproduction 6 (1991), 1206–1212.
7. Cortvrindt, RG, Hu, Y, Liu, J, Smitz, JE, Timed analysis of the nuclear maturation of oocytes in early preantral mouse follicle culture supplemented with recombinant gonadotropin. Fertility and Sterility 70 (1998), 1114–1125.
8. Devroey, P, Mannaerts, B, Sith, J, et al. Clinical outcome of a pilot study on recombinant human follicle stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonists regimens. Human Reproduction 9 (1994), 1064–1069.
9. European Recombinant Human LH Study Group, Recombinant luteinising hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. Journal of Clinical Endocrinology and Metabolism 83 (1998), 1507–1514.
10. Fevold, HL, Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 28 (1941), 33–36.
11. Filicori, M, The role of luteinising hormone in folliculogenesis and ovulation induction. Fertility and Sterility 71 (1999), 405–414.
12. Filicori, M, Cognigni, GE, Taraborrelli, S, et al. Luteinising hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. Journal of Clinical Endocrinology and Metabolism 84 (1999), 2659–2663.
13. Ganirelix Dose-Finding Study Group, A double-blind, randomised, dose-finding study to assess the efficacy of the gonadotropin-releasing hormone antagonist Ganerelix (Org 37462) to prevent premature luteinising hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Human Reproduction 13 (1998), 3023–3031.
14. Gemzell, CA, Dicfaluzy, E, Tillinger, KG, Human pituitary follicle-stimulating hormone. I: clinical effect of a partly purified preparation. CIBA Foundation Colloquia in Endocrinology 13 (1960), 191–200.
15. Germond, M, Dessole, S, Senn, A, et al. Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet, 339, 1992, 1170.
16. Hillier, SG, Whitelaw, PF, Smyth, CD, Follicular oestrogen synthesis; the ‘two-cell, two-gonadotrophin’ model revisited. Molecular and Cellular Endocrinology 100 (1994), 51–54.
17. Hull, ML, Corrigan, E, Piazzi, A, et al. Recombinant human luteinizing hormone: an effective new gonadotropin preparation. Lancet 344 (1994), 334–335.
18. Hull, ML, Livesey, JH, Evans, JJ, Benny, PS, The effect of recombinant follicle stimulating hormone (Gonal-F) on endogenous luteinizing hormone secretion in women. Human Reproduction 13 (1998), 1139–1143.
19. Laml, T, Obruca, A, Fischl, F, et al. Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women. Gynecological Endocrinology 13 (1999), 98–103.
20. Lévy, D, Navarro, JM, Schattman, GL, et al. The role of LH in ovarian stimulation. Exogenous LH: let's design the future. Human Reproduction 15 (2000), 2258–2265.
21. Lunenfeld, B, Sulimovici, S, Rabau, E, et al. L'induction de l'ovulation dans les amenorrhées hypophysaries par un traitment de gonadotrophins urinaries menopausique et de gonadotrophines chorionique. Comptes Rendues de la Societé Francaise de Gynecologie 5 (1962), 30–34.
22. Mannaerts, B, Shoham, Z, Schoot, D, et al. Single dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin deficient volunteers. Fertility and Sterility 59 (1993), 108–114.
23. Porchet, HC, Le Cotonnec, JY, Canali, S, et al. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone. Drug Metabolism and Disposition 21 (1993), 144–150.
24. Schoot, DC, Harlin, J, Shoham, Z, et al. Recombinant follicle-stimulating hormone and ovarian response in gonadotropin-deficient women. Human Reproduction 9 (1994), 1237–1242.
25. Scott Sills, EP, Levy, D, Moomjy, M, et al. A prospective randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Human Reproduction 14 (1999), 2230–2235.
26. Shoham, Z, Jacobs, HS, Insler, V, Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertility and Sterility 5 (1993), 1153–1161.
27. Smyth, CD, Miro, F, Whitelaw, PF, et al. Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 133 (1993), 1532–1538.
28. Steinkampf, MP, Mendelson, CR, Simpson, ER, Regulation by follicle stimulating hormone of the synthesis of aromatase p-450 in human granulosa cells. Molecular Endocrinology 1 (1987), 465–471.
29. Sullivan, MW, Stewart-Akers, A, Krasnow, JS, et al. Ovarian responses in women to recombinant follicle stimulating hormone and luteinizing hormone (LH): a role for the LH in the final stages of follicular maturation. Journal of Clinical Endocrinology and Metabolism 8 (1999), 228–232.
30. Weinbauer, GF, Simoni, M, Hutchinson, JS, et al. Pharmacokinetics and pharmacodynamics of recombinant and urinary human FSH in the male monkey (Macaca fascicularis). Journal of Endocrinology 141 (1994), 113–121.
31. Westergaard, LG, Erb, K, Laurse, S, et al. The effect of human menopausal gonadotropin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down regulated normogonadotropic women. Human Reproduction 11 (1996), 1209–1213.
32. Weston, AM, Zelinski-Wooten, MB, Hutchinson, JS, et al. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Human Reproduction 11 (1996), 608–613.
33. WHO 1973 Agents stimulating gonadal function in the human. Report of a WHO scientific group. WHO Technical Report Service, 514–929.
34. Yamoto, M, Shima, K, Nakano, R, Gonadotrophin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Hormone Research 37 (1992), 5–11.
35. Zeleznik, AJ, Hillier, SG, The role of gonadotropins in the selection of the pre-ovulatory follicle. Clinical Obstetrics and Gynaecology 27 (1984), 927–940.
36. Zeleznik, AJ, Hutchinson, JS, Schuler, HM, Passive immunization with anti-oestradiol antibodies during the luteal phase of the primate menstrual cycle potentates the perimenstrual rise in serum gonadotropin concentrations and stimulates follicular growth in the cynomolgus monkey. Journal of Reproduction and Fertility 80 (1987), 403–410.